Chinese guidelines on management of hepatic encephalopathy in cirrhosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE
    • Publication Information:
      Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
      Original Publication: Beijing : WJG Press, c1998-
    • Subject Terms:
    • Abstract:
      The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of hepatic encephalopathy (HE) including minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy, emphasizing the importance on screening MHE in patients with end-stage liver diseases. The guidelines emphasized that early identification and timely treatment are the key to improve the prognosis of HE. The principles of treatment include prompt removal of the cause, recovery of acute neuropsychiatric abnormalities to baseline status, primary prevention, and secondary prevention as soon as possible.
      Competing Interests: Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
      (©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.)
    • References:
      Gastroenterology. 2014 Apr;146(4):961-9. (PMID: 24365582)
      Eur J Gastroenterol Hepatol. 2017 Apr;29(4):456-463. (PMID: 28092641)
      Zhonghua Gan Zang Bing Za Zhi. 2015 Jul;23(7):533-7. (PMID: 26398846)
      Gut Microbes. 2014 May-Jun;5(3):397-403. (PMID: 24690956)
      Zhonghua Yi Xue Za Zhi. 2016 Feb 2;96(5):334-8. (PMID: 26875710)
      Ann Intern Med. 2013 Oct 15;159(8):522-31. (PMID: 24126646)
      J Clin Gastroenterol. 2014 Jul;48(6):491-9. (PMID: 24583758)
      Dig Dis Sci. 2017 Dec;62(12):3614-3621. (PMID: 29119412)
      Sci Rep. 2016 Jun 01;6:27092. (PMID: 27250065)
      Sci Rep. 2017 Nov 2;7(1):14947. (PMID: 29097814)
      Liver Int. 2009 Jul;29(6):789-96. (PMID: 19638107)
      Gastroenterology. 2017 Jan;152(1):134-141. (PMID: 27639806)
      J Gastrointestin Liver Dis. 2016 Jun;25(2):191-5. (PMID: 27308650)
      Cochrane Database Syst Rev. 2017 May 18;5:CD001939. (PMID: 28518283)
      Zhonghua Gan Zang Bing Za Zhi. 2013 Sep;21(9):641-51. (PMID: 24364073)
      Connect Tissue Res. 2018 Jan;59(1):85-98. (PMID: 29099240)
      Therap Adv Gastroenterol. 2016 Sep;9(5):684-91. (PMID: 27582881)
      Aliment Pharmacol Ther. 2011 Apr;33(7):739-47. (PMID: 21306407)
      Am J Gastroenterol. 2001 Jul;96(7):1968-76. (PMID: 11467622)
      Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G168-75. (PMID: 21940902)
      Hepatol Res. 2015 Aug;45(8):880-9. (PMID: 25266207)
      Metab Brain Dis. 2004 Dec;19(3-4):345-9. (PMID: 15554426)
      J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S7-S20. (PMID: 26041962)
      PLoS One. 2017 Feb 1;12(2):e0171211. (PMID: 28146589)
      J Korean Med Sci. 2017 Sep;32(9):1484-1490. (PMID: 28776344)
      Eur J Gastroenterol Hepatol. 2016 Feb;28(2):146-52. (PMID: 26600154)
      Rev Esp Enferm Dig. 2017 Oct;109(10):736-737. (PMID: 28929776)
      PLoS One. 2016 Jan 08;11(1):e0146076. (PMID: 26745876)
      J Infect. 2007 Jan;54(1):98-102. (PMID: 17049992)
      Biol Trace Elem Res. 2016 Feb;169(2):153-8. (PMID: 26129828)
      OMICS. 2015 Jun;19(6):339-45. (PMID: 26415140)
      J Clin Pharm Ther. 2010 Jun;35(3):333-41. (PMID: 20831534)
      World J Hepatol. 2016 Oct 28;8(30):1279-1286. (PMID: 27843538)
      Hepatol Int. 2018 Feb;12(Suppl 1):135-147. (PMID: 28770516)
      Complement Ther Med. 2014 Dec;22(6):977-85. (PMID: 25453517)
      J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S42-8. (PMID: 26041957)
      Ann Neurol. 2016 May;79(5):806-825. (PMID: 26950270)
      Liver Int. 2017 Feb;37(2):212-223. (PMID: 27388776)
      Ann Hepatol. 2017 Jan-Feb 2017;16(1):115-122. (PMID: 28051800)
      Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):65-6. (PMID: 21272466)
      Nutr Clin Pract. 2013 Oct;28(5):580-8. (PMID: 23945292)
      J Steroid Biochem Mol Biol. 2016 Jun;160:94-7. (PMID: 26589093)
      Clin Gastroenterol Hepatol. 2015 Oct;13(10):1828-1835.e1. (PMID: 24846278)
      Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):604-8. (PMID: 25243962)
      J Gastroenterol Hepatol. 2013 May;28(5):783-92. (PMID: 23425108)
      Eur Radiol. 2013 Dec;23(12):3370-8. (PMID: 23839169)
      Liver Int. 2019 Apr;39(4):684-693. (PMID: 30554466)
      Metab Brain Dis. 2016 Oct;31(5):1151-6. (PMID: 27353278)
      Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):546-7. (PMID: 24298662)
      Hepatology. 2006 Apr;43(4):698-706. (PMID: 16557540)
      Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):664-677. (PMID: 29108189)
      Liver Int. 2017 Jul;37(7):1013-1022. (PMID: 27988985)
      J Hepatol. 2007 Jul;47(1):67-73. (PMID: 17459511)
      Brain Imaging Behav. 2019 Jun;13(3):771-780. (PMID: 29846883)
      Metab Brain Dis. 2017 Apr;32(2):595-605. (PMID: 28070704)
      Am J Clin Nutr. 2010 Jul;92(1):137-40. (PMID: 20444959)
      J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1362-8. (PMID: 25589780)
      PLoS One. 2017 Oct 11;12(10):e0185412. (PMID: 29020023)
      Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):834-840. (PMID: 29325277)
      Hepatology. 2017 Jul;66(1):198-208. (PMID: 28271528)
      Clin Rev Allergy Immunol. 2018 Apr;54(2):282-294. (PMID: 29256057)
      Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):257-262. (PMID: 28494543)
      Ann Surg. 2017 Oct;266(4):677-684. (PMID: 28692474)
      J Gastroenterol Hepatol. 2010 May;25(5):858-63. (PMID: 20546438)
      Liver Int. 2015 Dec;35(12):2487-94. (PMID: 26332169)
      Eur J Radiol. 2013 Nov;82(11):1981-8. (PMID: 23849331)
      Gut Liver. 2016 Jul 15;10(4):509-19. (PMID: 27377741)
      World J Gastroenterol. 2017 Sep 14;23(34):6321-6329. (PMID: 28974899)
      J Hepatol. 2011 Jan;54(1):72-7. (PMID: 20934771)
      J Gastroenterol Hepatol. 2010 Jun;25(6):1029-41. (PMID: 20594216)
      Zhonghua Gan Zang Bing Za Zhi. 2013 May;21(5):385-8. (PMID: 24025143)
      Hepatol Res. 2017 Dec;47(13):1359-1367. (PMID: 28199774)
      J Hepatol. 2014 Sep;61(3):642-59. (PMID: 25015420)
      Clin Gastroenterol Hepatol. 2017 Apr;15(4):565-574.e4. (PMID: 27720916)
      Gastroenterol Hepatol (N Y). 2016 Feb;12(2):91-100. (PMID: 27182210)
      Gastroenterology. 2015 Nov;149(6):1483-9. (PMID: 26299413)
      World J Gastroenterol. 2013 Aug 14;19(30):4984-91. (PMID: 23946605)
      Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):619-25. (PMID: 23830279)
      Liver Int. 2016 Jul;36(7):986-93. (PMID: 26561214)
      Hepatology. 2002 Mar;35(3):716-21. (PMID: 11870389)
      J Multidiscip Healthc. 2017 Mar 24;10:113-119. (PMID: 28392702)
      Cochrane Database Syst Rev. 2016 May 06;(5):CD003044. (PMID: 27153247)
    • Contributed Indexing:
      Keywords: Diagnosis; Hepatic encephalopathy; Liver cirrhosis; Therapy
    • Publication Date:
      Date Created: 20191003 Date Completed: 20200226 Latest Revision: 20231014
    • Publication Date:
      20231215
    • Accession Number:
      PMC6767982
    • Accession Number:
      10.3748/wjg.v25.i36.5403
    • Accession Number:
      31576089